Description

Ribavirin Capsules

Healthy Inc is a specialized global supplier and exporter of advanced, life-saving antiviral therapeutics. We provide high-purity Ribavirin Capsules (200 mg), manufactured in WHO–GMP certified, dedicated oral solid dosage facilities. This “Synthetic Nucleoside Analogue” is a massive-volume, highly strategic export to hepatology centers, infectious disease hospitals, NGO epidemic response teams, and government health ministries in Africa, LATAM, and Southeast Asia, serving as a critical intervention for Chronic Hepatitis C (HCV) eradication and the management of endemic viral hemorrhagic fevers.

Product Overview

This formulation contains Ribavirin, a synthetic guanosine nucleoside analogue with broad-spectrum activity against many RNA and DNA viruses.

The “Lethal Mutagenesis” Specialist:

• Mechanism (IMPDH Inhibition & Mutagenesis): Ribavirin’s mechanism is multi-faceted. Once inside the cell, it is phosphorylated to its active form. It competitively inhibits the enzyme Inosine Monophosphate Dehydrogenase (IMPDH), severely depleting intracellular pools of guanosine triphosphate (GTP), which the virus requires to replicate. Furthermore, it acts as a defective nucleotide; when the viral RNA polymerase mistakenly incorporates Ribavirin into the growing viral genome, it causes catastrophic, lethal mutations that destroy the virus’s ability to survive (“lethal mutagenesis”).
• The Hepatitis C Adjunct: Historically used with Pegylated Interferon, Ribavirin is now heavily procured to be administered alongside modern Direct-Acting Antivirals (DAAs like Sofosbuvir or Velpatasvir) for patients with decompensated cirrhosis or difficult-to-cure HCV genotypes, drastically increasing the Sustained Virologic Response (SVR) rate.
• Epidemic & Hemorrhagic Fever Utility: Ribavirin is one of the only globally available, cost-effective oral interventions deployed during outbreaks of Lassa Fever, Crimean-Congo Hemorrhagic Fever (CCHF), and severe RSV (Respiratory Syncytial Virus), making it a massive priority for NGO emergency stockpiles.

Product Composition & Strength

We supply this product as a Hard Gelatin Capsule, packed in highly secure, moisture-resistant Alu-Alu blister strips or high-density polyethylene (HDPE) bottles.

*Pack Sizes: 10×10 Alu-Alu Blisters or 84/168-Capsule HDPE Bottles (Optimized specifically for 4-week HCV treatment cycles).

Technical & Logistics Specifications

Critical data for Pharmaceutical Importers and Outbreak Response NGOs.

Manufacturing Authority

Marketed and Distributed by Healthy Inc from WHO-GMP & ISO 9001:2015 certified units.

• Teratogenic Handling & Containment: Ribavirin is highly teratogenic and embryocidal. Our manufacturing is executed within strictly isolated, negative-pressure encapsulation suites utilizing specialized barrier technology. This completely protects facility personnel from airborne powder exposure and guarantees zero cross-contamination with non-antiviral pharmaceutical lines.
• Optimized Bioavailability: Formulated with premium superdisintegrants to ensure rapid gastric dissolution, allowing the drug to achieve reliable peak serum concentrations and immediate intracellular phosphorylation necessary for suppressing aggressive viral loads.

Therapeutic Indications (Human Use)

Indicated for the treatment of severe viral infections:

• Chronic Hepatitis C (HCV): Indicated strictly in combination with other anti-HCV drugs (e.g., Sofosbuvir, Velpatasvir, or Pegylated Interferon alfa-2a) for the treatment of chronic hepatitis C virus infection.
• Viral Hemorrhagic Fevers (Off-Label/Stockpile): Utilized by global health agencies for the treatment and post-exposure prophylaxis of Lassa fever and Crimean-Congo Hemorrhagic Fever.

Dosage & Administration

Recommended Dosage (Strictly as per Hepatologist/Infectious Disease Specialist):

• Administration (CRITICAL FOOD RULE): Ribavirin capsules MUST be taken with food. Taking it with a high-fat meal massively increases the drug’s oral bioavailability and peak plasma concentration, which is essential for virologic clearance.
• HCV Weight-Based Dosing:
  – Adults weighing < 75 kg: 1000 mg per day (administered as 400 mg in the morning and 600 mg in the evening).
  – Adults weighing ≥ 75 kg: 1200 mg per day (administered as 600 mg in the morning and 600 mg in the evening).
• Monotherapy Warning: Must NEVER be used as monotherapy for Hepatitis C, as it is ineffective alone and rapid resistance or treatment failure will occur.

Safety Warnings (CRITICAL):

• BLACK BOX WARNING (Teratogenicity – Category X): Ribavirin causes massive, catastrophic birth defects. It is strictly contraindicated in women who are pregnant and in the male partners of women who are pregnant. Extreme care must be taken to avoid pregnancy during therapy and for 6 months post-therapy utilizing at least two reliable forms of contraception.
• BLACK BOX WARNING (Hemolytic Anemia): The primary dose-limiting toxicity of Ribavirin is severe hemolytic anemia. Hemoglobin levels frequently drop precipitously within the first 1 to 2 weeks of therapy, which can worsen underlying cardiac disease or lead to fatal myocardial infarctions. Hemoglobin and complete blood counts must be strictly monitored.

Global Export & Contract Manufacturing Services

Healthy Inc stands as a premier Pharmaceutical Exporter in India, dedicated to serving the needs of international Pharma Traders, Wholesalers, and Bulk Drug Distributors. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) services for Advanced Antiviral Formulations, allowing brands to launch high-quality generic medicines under their own label. Whether you are looking for a reliable NGO Tender Supplier for global health procurement in Africa or a B2B Pharma Marketplace partner for Latin America, our logistics network ensures timely delivery. We actively support Pharmaceutical Drop Shipping models and bulk indenting, ensuring that every Generic Medicine Wholesaler receives WHO-GMP certified products at competitive rates.